Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

Abstract Background Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used for rheumatoid arthritis (RA) treatment. However, little is known based on contemporary data about the factors associated with DMARDs and patterns of use of biologic DMARDs for initial and subsequent RA...

Полное описание

Библиографические подробности
Главные авторы: Yinzhu Jin, Rishi J. Desai, Jun Liu, Nam-Kyong Choi, Seoyoung C. Kim
Формат: Статья
Язык:English
Опубликовано: BMC 2017-07-01
Серии:Arthritis Research & Therapy
Предметы:
Rheumatoid arthritis
Antirheumatic agents
Biologic therapy
Online-ссылка:http://link.springer.com/article/10.1186/s13075-017-1366-1

Internet

http://link.springer.com/article/10.1186/s13075-017-1366-1

Схожие документы